The AR inhibitor fidarestat potentiated tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known to kill tumor cells selectively by inducing the death receptors (DR)-4 and DR-5. The gene discussed is TNFSF10; the disease is neoplasm.